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Abstract 
Monosodium glutamate (MSG) of brand name “Ajinomoto” was purchased from Nsukka Market and was 
administered to wistar rat. Twenty four wistar rats were randomly divided into four groups housed in different 
cages.  The rats were administered with varying doses (500, 1000 and 1500 mg/kg body weights) of MSG. The 
effect on some haematological parameters; WBC, PCV, Hb, sodium ion (Na+), potassium ion (K+) blood urea 
nitrogen (BUN) chloride ion (Cl-) creatinine (Cr2+), and bicarbonate (HCO3-) were investigated. There was an 
insignificant difference (P > 0.05) in PCV, Hb and WBC levels of the test groups, compared with the control 
group. The serum electrolyte; creatinine (Cr2+), of the group administered 1500mg/kg body weight of MSG 
showed significant difference (P<0.05), when compared with control while other serum electrolytes sodium, 
potassium, urea, carbonate and chloride showed no difference (P>0.05).  
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1 Introduction 
Monosodium glutamate (MSG) is the sodium salt of the amino acid, glutamic acid. It is sold as a fine white 
crystalline substance, similar in appearance to table salt (NaCl) and sugar. It does not have a distinct taste and 
how it adds flavour to other foods is not fully understood (FASEB and FDA 1995). It is used as a flavour 
enhancer in a variety of foods prepared at homes, in restaurants and by food processors (FASEB and FDA, 
2005). The body uses glutamate as a neurotransmitter in the brain and there are glutamate responsive tissues in 
other parts of the body as well (Choi 1988). It has been reported that the injection of glutamate into laboratory 
animals have resulted in damage to the nerve cells in the brain (Kubo et al 2004). 
The kidneys are a pair of fist-sized organ located outside the peritoneal cavity on each side of the 
spine. The human kidneys are two bean-shaped organs, one on each side of the backbone. It represents about 
0.5% of the total weight of the body but receive 20-25% of the total arterial blood pumped by the heart; each 
contains from one to two million nephrons (Klahr and Miller, 1998).   
The Kidneys are highly specialized organs that maintain the internal environment of the body by 
selectively excreting or retaining various substances according to specific body needs. The kidney is more than 
just an excretory organ. It does remove waste, but it also removes normal components of the blood that are 
present in greater-than-normal concentrations. When excess water, sodium ions, calcium ions, potassium ions 
and so on are present, the excess quickly passes out in the urine. On the other hand, the kidneys step up their 
reclamation of these substances when they are present in the blood in less than normal amounts (Stewart, 1998). 
Thus the kidney continuously regulates the chemical composition of the blood within narrow limits. The kidney 
is one of the major homeostatic devices of the body. The human kidney is also an endocrine gland secreting two 
hormones; Erythropoietin (EPO), and Calcitrol (1,25 dihydroxyl
 
Vitamin D3), the active form of vitamin D. The 
kidney is also the organ where the enzyme rennin is produced (Meyer and Hostetter, 2007).  
Kidneys are crucial organs for excretion of metabolic waste products and regulation of volume, pH, 
electrolyte composition as well as osmolarity of the extracellular body fluid including plasma (Meyer and 
Hostetter, 2007).  
The kidney allows a person to eat and drink according to his/her habit without changing the composition of fluid 
compartments. This is achieved by the following processes: 
• Retention of substances vital to the body such as protein and glucose.  
• Maintenance of acid/base balance  
• Excretion of waste products, water soluble toxic substances and drugs.  
• Endocrine functions.  
Monosodium glutamate (MSG) is used as a flavour enhancer in a variety of foods prepared both at 
homes, in restaurants and by food processors in most parts of the world including Nigeria. 
For the past 30 years, the use of MSG has been controversial. Its safety has been doubted because of 
reports (FDA, 1996) of adverse reaction in people who have eaten food that contain MSG. Many researches 
(FDA, 1996, FASEB, 1996) on the role of glutamate in the nervous system have also raised questions on the 
chemical safety of MSG. A number of other works have also found no adverse effects occasioned by the 
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utilization of MSG foods (FASEB and FDA 1995, George, 2004).  
This work was therefore designed to evaluate the safety of MSG as a food enhancer by evaluating the 
effect of MSG on Haemoglobin (Hb) concentration, Parked cell volume (PCV), White blood cells (WBC) count 
and the kidney function, using some serum electrolytes (Sodium (Na+), Potassium (K+), Chloride (Cl-), 
Bicarbonate (HC −3O ), Blood urea Nitrogen (BUN) and Creatinine) as an indirect approach. 
 
2 MATERIALS AND METHODS  
2.1 Procurement and Management of Animals 
The animals used for the study were 8 weeks old adult male Wistar rats weighing between 110 g and 230 g, 
obtained from the animal houses of the Faculty of Veterinary Medicine and Faculty of Pharmaceutical Sciences, 
University of Nigeria Nsukka (UNN). The feeds used for the study were normal rat diet chow bought from King 
Size feed and mill flour limited, Nsukka  
2.1.1 Experimental Design/Treatment of Animals   
Forty rats were acclimatized to the laboratory environment for seven days and then assigned to four groups of 
ten rats each. Administration of MSG was by oral intubation. The rats were maintained on normal rat chow 
bought from King-size and flour mill Ltd, Nsukka, Enugu State.  
The animals were fed ad libitum on the chow and water throughout the duration of the experiment. The groups 
were as follows:  
Group I was the control group and was administered distilled water only (2 ml/kg). 
Group II was administered with 0.5 g/kg body weight of monosodium glutamate dissolved in distilled water 
(250 mg/ml).  
Group III was administered with 1.0g/kg body weight of monosodium glutamate dissolved in distilled water 
(250 mg/ml).   
Group IV was administered with 1.5g/kg body weight of monosodium dissolved in distilled water (250 
mg/ml). 
The rats in groups II, III and IV were given MSG 3 times a day, 7 days a week for 4 weeks.  
2.1.2Animal Sacrifice and Sample Collection  
All rats were sacrificed on day 28. The blood from the rats were collected through the ocular vein and allowed to 
clot, centrifuged and the serum separated from the cells. This was used for the analysis. 
 
2.2 Estimation of Biochemical Parameters 
Estimation of Haemoglobin (Hb) Concentration was done using the method of Drabkin and Austin (1935), 
Parked Cell Volume (PCV) was by Capillary tube method, (Microhaematocrit), as found in Baker et al., (2004) 
and the assay of White Blood Count (WBC) was done using Turks Solution (Baker and Silverton, 1985) 
Assay of Blood Urea Nitrogen (BUN) was by DAM method, Serum Bicarbonate (HCO3-) by Forrester 
et al, 1976 method, Chloride  by Skeggs and Hochestrasser 1964 method, Serum Potassium Ions by Terri and 
Sesin, 1958 method,  Serum Sodium by Maruna, 1958 method,  Serum Creatinine by the method based on the 
principle that creatinine in alkaline solution.  
 
2.3 Statistics 
The results were expressed as means ± SD and tests of statistical significance were carried out using one-way 
analysis of variance (ANOVA). The statistical package used was Genstat Release 4.23D lawes Agricultural 
Trust (Rothamsted Experimental Station). The acceptable level of significance was P<0.05 using a 2-tailed 
distribution. 
 
3 RESULTS AND DISCUSSION 
Table 1: In Vivo effect of varied concentration of MSG on Parked Cell Volume of Wistar Rats 
Group Dose (g/kg b.w) %PCV % change PCV 
1 0.00 57.50 ± 1.71 0.0 
2 0.50 55.00 ± 2.48 - 4.3 
3 1.00 55.75 ± 1.11 - 3.0 
4 1.50 53.25 ± 2.84 - 7.4 
n = 10, Results are means  ± S.D, Statistical significant difference (p≤ 0.05) 
The results on table 1 shows that there was a reduction in the level of the packed cell volume of the test groups 
given the varying doses 500mg/kg, 1000mg/kg and 1500mg/kg body weight of MSG compared to the control. 
However, these reductions were not statistically significant (P > 0.05).  
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Table 2: In Vivo effect of varied concentration of MSG on Haemoglobin of Wistar Rats 
Group Dose (g/kg b.w) Hb(g/dl) % change in Hb 
1 0.00 16.40 ± 0.55 0.0 
2 0.50 17.53 ± 0.74 6.9 
3 1.00 17.70 ± 0.46 7.9 
4 1.50 16.89 ± 0.78 1.8 
n = 10, Results are means  ± S.D, Statistical significant difference (p≤ 0.05) 
Table 2 shows insignificant difference in haemoglobin (p > 0.05) of groups administered varying doses 
500mg/kg, 1000mg/kg and 1500mg/kg body weight of MSG compared to the control group.   
Table 3: In Vivo effect of varied concentration of MSG on White Blood Cell of Wistar Rats 
Group Dose (g/kg b.w) WBC(cell/dm3) % change in WBC 
1 0.00 5325.00 ± 1000.30 0.0 
2 0.50 3269.00 ± 2919.91 - 38.6 
3 1.00 7150.00 ± 1632.23 34.3 
4 1.50 7175.00 ± 1687.87 34.7 
n = 10, Results are means  ± S.D, Statistical significant difference (p≤ 0.05) 
The results on table 3 shows that there was a reduction in the level of WBC of the test group administered 
500mg/kg body weight of MSG compared to the control. It also shows that there was an increase in the level of 
WBC of the groups given both 1000mg/kg and 1500mg/kg body weight of MSG relative to the control group. 
These differences were not statistically significant (P > 0.05).  
Table 4: In Vivo effect of varied concentration of MSG on serum creatinine of Wistar Rats 
Group Dose (g/kg b.w) creatinine (mg/dl.) % change of creatinine 
1 0.00 1.25 ± 0.18 0.0 
2 0.50 1.23 ± 0.47 - 1.6 
3 1.00 1.58 ± 0.17 26.4 
4 1.50 2.10 ± 0.12 68.0 
n = 10, Results are means  ± S.D, Statistical significant difference (p≤ 0.05) 
The results in table 4 shows an insignificant reduction (P > 0.05) in the level of serum creatinine of the test group 
administered 500mg/kg body weight of MSG and an insignificant increase (P > 0.05) in the creatinine level of 
the test group given 1000mg/kg body weight of MSG compared to the control group. However, the creatinine 
level of the group administered 1500mg/kg body weight of MSG increased significantly (P < 0.05) compared to 
control group.  
Table 5: In Vivo effect of varied concentration of MSG on Potassium ion of Wistar Rats 
Group Dose (g/kg b.w)               K+ (mkq/1) % change of K+ 
1 0.00 3.83 ± 0.10             0.0 
2 0.50 3.55 ± 0.05           - 7.31 
3 1.00 3.90 ± 0.01             1.8 
4 1.50 3.75 ± 0.05            - 2.1 
n = 10, Results are means  ± S.D, Statistical significant difference (p≤ 0.05) 
Table 5 shows that there was no significant reduction (P > 0.05) in the level of serum potassium of the test 
groups administered 500mg/kg and 1500mg/kg body weight of MSG compared to the control group. There was 
also no significant increase (P >0.05) in the potassium level of the test group given 100mg/kg body weight 
compared with control group.  
Table 6: In Vivo effect of varied concentration of MSG on serum Sodium ion of Wistar Rats 
Group Dose (g/kg b.w)               Na+ (mmol/1) % change of Na+ 
1 0.00 133.50 ± 2.10 0.0 
2 0.50 138.75 ± 2.43 3.8 
3 1.00 135.25 ± 1.03 1.5 
4 1.50 131.50 ± 0.87 - 1.5 
n = 10, Results are means  ± S.D, Statistical significant difference (p≤ 0.05) 
The results on table 6 shows an increase in serum sodium level of the test groups administered both 500mg/kg 
and 1000mg/kg body weight of MSG compared to the control group. A reduction in the level of sodium ions of 
the test group administered 1500mg/kg body weight of MSG was observed. These differences were not 
statistically significant (P > 0.05) 
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Table 7: In Vivo effect of varied concentration of MSG on serum Trioxocarbonate of Wistar Rats 
Group Dose (g/kg b.w) HCO3 (mmol/l) % change of HCO3 
1 0.00 25.0 ± 0.58 0.0 
2 0.50 26.0 ± 0.00 4.0 
3 1.00 26.0 ± 0.82 4.0 
4 1.50 24.5 ± 1.00 - 2.0 
n = 10, Results are means  ± S.D, Statistical significant difference (p≤ 0.05) 
The result expressed table 7 shows an increase in the level of serum hydrogen trioxocarbonate IV of the test 
groups administered both 500mg/kg and 1000mg/kg body weight of MSG and a decrease in the test group given 
1500mg/kg body weight of MSG compared with control group respectively. These differences were not 
statistically significant (P > 0.05). 
Table 8: In Vivo effect of varied concentration of MSG on serum Chloride ions of Wistar Rats 
Group Dose (g/kg b.w) Cl-(ml/l) % change of Cl- 
1 0.00 76.00 ± 1.00 0.0 
2 0.50 81.75 ± 5.65 7.6 
3 1.00 78.25 ± 2.75 3.0 
4 1.50 69.50 ± 2.18 - 8.6 
 
n = 10, Results are means  ± S.D, Statistical significant difference (p≤ 0.05) 
Table 8 shows that there were no significant changes (P > 0.05) between the levels of serum chloride of the 
control group and that of the test groups given MSG. 
Table 9: In Vivo effect of varied concentration of MSG on serum Blood Urea of Wistar Rats 
Group Dose (g/kg b.w) Blood Urea(ml/dl)      % change of Blood Urea 
1 0.00 6.35 ± 0.46 0.0 
2 0.50 6.98 ± 0.34 9.9 
3 1.00 6.40 ± 0.33 0.8 
4 1.50 9.05 ± 1.01 42.5 
n = 10, Results are means  ± S.D, Statistical significant difference (p≤ 0.05) 
The results on table 9 showed that only the group given 1500mg/kg body weight of MSG had a statistically 
significant (P < 0.05) increase in the level of serum urea. The group administered both 500mg/kg and 
1000mg/kg body weight of MSG had no statistically significant increase (P > 0.05) in the level of serum Urea.  
 
4. DISCUSSION 
Monosodium glutamate is widely used as a food additive and flavour enhancer in a variety of foods prepared at 
homes, in restaurants and by food processors in today’s world (FASEB 1996; FDA 1996), although its effect on 
the body chemistry remains controversial (George, 2004). 
The haemoglobin, WBC and PCV were evaluated. There was an insignificant difference (P > 0.05) in 
PCV, Hb and WBC levels of the test groups administered MSG compared with the control group. These 
insignificant difference (P > 0.05) in level of PCV, Hb and WBC of the test groups compared with the control is 
consistent with the finding of Laura et al, (2004) and Baker et al, (2005) which showed that MSG does not alter 
the PCV, Hb and WBC level.  
The result of this study show an insignificant difference (P > 0.05) in the creatinine level of the test 
groups administered 500mg/kg and 1000mg/kg body weight of MSG compared with that of the control. This 
result is in agreement with the work of Voits et al, (2003) who reported that MSG does not alter the creatinine 
level. However, they show a significant difference (P < 0.05) in creatinine level of the test group administered 
1500mg/kg body weight of MSG compared to the control. This result is at variance with the works of Meldrum, 
(1993) and Voits et al, (2003) which showed that MSG does not alter creatinine level. This variance might be 
due to the species of animal used in this study; adult rats as against postnatal female mice used by Voits et al 
(2003). It might also be due to the dosage of MSG used in this study 1500mg/kg body weight of MSG as against 
4mg/g used by Meldrum, (1993). 
There was an insignificant difference (P > 0.05) in serum potassium and sodium levels of the test 
groups compared with the control. This is consistent with the work of Meldrum, (1993) and Choi et al, (2004) 
which showed that MSG does not alter the serum potassium and sodium level. 
The results also show an insignificant difference (P > 0.05) in serum hydrogen trioxocarbonate (HCO3) 
levels of the test groups compared with the control group.  These results are in agreement with the works of 
Zhang et al, (1996) and Mozes et al, (2004) which showed that MSG does not alter HCO3 level. 
There was an insignificant difference (P > 0.05) in serum chloride and blood urea nitrogen (BUN) of 
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the test groups administered 500mg/kg and 1000mg/kg body weight of MSG compared with the control. This 
result is in agreement with the findings of Zhang et al, (1996) and Mozes et al, (2004) which reported that MSG 
does not alter chloride and blood urea nitrogen levels in MSG treated mice. A significant decrease (P < 0.05) in 
serum blood urea nitrogen of the test group administered 1500mg/kg body weight of MSG was observed in this 
work relative to the control group. These results is at variance with the findings of Zhang et al, (1996), Voits et 
al, (2003) and Mozes et al, (2004) which reported that MSG does not alter blood urea nitrogen level. This 
discrepancy might be due to the dosage, species or sex of animals used in this work: Adult male rats as against 
female mice. 
There was an insignificant difference (P > 0.05) in PCV, Hb and WBC levels of the test groups 
administered MSG compared with the control group. These insignificant difference (P > 0.05) in level of PCV, 
Hb and WBC of the test groups compared with the control is consistent with the finding of Laura et al, (2004) 
and Baker et al, (2005) which showed that MSG does not alter the PCV, Hb and WBC level.  
 Enemali and Danielson (2013), suggested that MSG may have been hazardous to the health of the test 
animals used in the work. They observed that varying doses 500mg/kg, 1000mg/kg and 1500mg/kg body weight 
of MSG significantly reduced the brain lipid levels of the test animals; hence this might lead to a state of 
depression of the brain.  
We also reported earlier that although the use of monosodium glutamate may lead to the alteration of 
the activities of the liver enzymes in the serum, the changes were not significant enough to suggest the disruption 
of the architecture of the liver and/or other tissues bearing the enzymes (Enemali and Danielson, 2014).  
In this present study, it has been found that, although there were changes (noticed in the concentrations 
of the serum electrolytes with the exception of  creatinine and blood urea of the animals administered with 
1500mg/kg body weight), non was found to be significant to suggest the disruption of the metabolic activities of 
the kidney. 
 
5. Conclusion 
From the foregoing, it can be concluded that apart from the brain lipid which was significantly altered (Enemali 
and Danielson, 2013), the in vitro serum enzyme (AST, ALT and ALP) activities, were unaltered (Enemali and 
Danielson, 2014) and also the kidney metabolic functions and other haematological parameters assayed here, 
were undisrupted. Our studies therefore, concludes that if the MSG can be barred from crossing the blood brain 
barrier and used in concentrations less than 1500mg/kg bw (which significantly increased the creatinine and 
BUN), it could be certified safe for consumption based on the parameters assessed in these studies. 
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